Krystal Biotech (KRYS) Change in Inventory (2023 - 2026)

Krystal Biotech has reported Change in Inventory for 4 years, with the latest figure at $958000.0 in Q2 2026.

• Change in Inventory for Q2 2026 came in at $958000.0, up 208.86% year-over-year; the trailing twelve-month figure through Jun 2026 was $7.0 million (down 34.93% YoY), and the FY2025 annual result was $6.3 million, down 47.21% from the prior year.
• Change in Inventory climbed to $958000.0 in Q2 2026, from $243000.0 in the prior quarter.
• Over five years, Change in Inventory peaked at $6.5 million in Q4 2024 and troughed at -$880000.0 in Q2 2025.
• A 4-year average of $1.8 million and a median of $1.1 million in 2025 frame the typical range for Change in Inventory.
• The largest YoY upside for Change in Inventory was 1225.41% in 2024 against a maximum downside of 158.5% in 2024.
• A 4-year view of Change in Inventory shows it stood at $492000.0 in 2023, then jumped by 1225.41% to $6.5 million in 2024, then slumped by 83.78% to $1.1 million in 2025, then retreated by 9.45% to $958000.0 in 2026.
• Per Business Quant data, the three most recent Change in Inventory figures were $958000.0 in Q2 2026, $243000.0 in Q1 2026, and $1.1 million in Q4 2025.